Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy
Nia JulianFebruary 24, 2026
Facebook0 Twitter Pinterest0 0 Likes
Previous

Rallybio to acquire Candid Therapeutics

Nia JulianMarch 9, 2026
Next

GSK pays $2.2B to buy Rapt for its phase 2-stage food allergy challenger to Xolair

Nia JulianJanuary 20, 2026

© 2020 Solasta Ventures. All Rights Reserved.